Title of article
Inhibition of drug-induced DNA fragmentation, but not cell death, of glioma cells by non-caspase protease inhibitors
Author/Authors
Eitel، نويسنده , , Katrin and Wagenknecht، نويسنده , , Bettina and Weller، نويسنده , , Michael، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
6
From page
11
To page
16
Abstract
The role of non-caspase protease activation in drug-induced cell death of glioma cells was examined. Neither calpain inhibitors I or II, phenylmethylsulfonyl fluoride (PMSF), Nα -p-tosyl-l-lysine chloromethyl ketone (TLCK), N-tosyl-l-phenylalanine chloromethyl ketone (TPCK), E64, leupeptin nor pepstatin inhibit the cytotoxicity of vincristine, cisplatin, doxorubicin, cytarabine, camptothecin, BCNU or VM26 in two malignant glioma cell lines, T98G and LN-229. However, DNA fragmentation induced by VM26 is inhibited by calpain inhibitor I, PMSF, TLCK and TPCK, and that induced by camptothecin by calpain inhibitors I and II and TPCK. Moreover, protease inhibitors fail to abrogate CD95 ligand-induced apoptosis even though DNA fragmentation is attenuated by calpain inhibitor II and TPCK. Thus, non-caspase protease activation is not required for drug-induced apoptosis of glioma cells. Protease inhibitor-mediated inhibition of DNA fragmentation operates downstream of the commitment point for cell death.
Keywords
Glioma , Protease inhibitors , chemotherapy , DNA fragmentation
Journal title
Cancer Letters
Serial Year
1999
Journal title
Cancer Letters
Record number
1800347
Link To Document